
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced form, metabolic dysfunction-associated steatohepatitis (MASH), have a link to chronic diseases, especially metabolic syndrome. This is a group of conditions that happen together and raise your risk of other chronic conditions, such as
- Obesity
- Type 2 diabetes
- Insulin resistance
- Hypertension
- Metabolic disorders such as dyslipidemia (high levels of fat in the blood)
Not only do MASLD and MASH affect your liver, but they also increase the likelihood of diseases in your heart and blood vessels. Inflammation and buildup of fat in the liver can lead to atherosclerosis (hardening of the arteries) and heart disease.
When liver disease worsens, it can cause severe liver problems such as fibrosis (scarring), cirrhosis (severe scarring), and even liver cancer.
In the United States, experts think that between 75 million and 100 million people have MASLD. Hispanic people are among the most affected. Experts believe that nearly half of this population has metabolic syndrome and liver disease – and many are unaware of it.
What Is MASLD?
Metabolic dysfunction-associated steatotic liver disease (MASLD) used to be called nonalcoholic fatty liver disease (NAFLD). It’s a condition marked by an excessive buildup of fat in the liver, known as hepatic steatosis. It worsens over several years and often has no symptoms.
MASLD affects approximately 42% of adults in the U.S. According to a recent study, four to 10 out of 100 people get the disease.
An early diagnosis, along with lifestyle changes, can help prevent, slow down, or even reverse liver damage.
What Is MASH?
Some people with MASLD may develop the more severe and advanced form of the disease, called MASH. It involves chronic inflammation, liver cell damage, and tissue scarring.
An estimated 5% to 12% of people with MASH could go on to have progressive fibrosis, which leads to liver cirrhosis and is linked to a higher risk of liver cancer.
MASLD and MASH, and Their Link to Chronic Diseases
MASLD and MASH have a connection to several chronic diseases, including:
Obesity and metabolic syndrome:
- Obesity increases the risk of liver inflammation and fibrosis, key factors in the development of MASH.
- Metabolic syndrome with insulin resistance, dyslipidemia, and excess belly fat are other risk factors for MASLD/MASH.
- In people with MASLD, dyslipidemia raises LDL ("bad") cholesterol, increases triglyceride levels, and lowers HDL ("good") cholesterol. These imbalances happen to 60%-70% of people with MASLD.
Type 2 diabetes:
- About 22.5% of people with MASLD and 43.6% of those with MASH have type 2 diabetes.
- Nearly 80% of people with MASLD may also have type 2 diabetes.
- Insulin resistance, which is a key marker of type 2 diabetes, leads to increased fat buildup in the liver and the development of MASLD.
Cardiovascular diseases and hypertension (high blood pressure):
- MASLD affects up to 70% of people who have diseases of the heart and blood vessels (also called cardiovascular diseases).
- If you have high blood pressure, it can cause MASLD to worsen faster.
- MASLD adds to plaque buildup in your arteries, raising your risk of heart attacks and strokes.
- People with MASLD may get ischemic heart disease, cardiomyopathy (a disease that weakens heart muscle), and arrhythmias.
Chronic kidney disease:
- About 20% to 50% of people with MASLD also have chronic kidney disease. This may mean that MASLD may make kidney disease worsen faster, even without other risk factors such as hypertension or type 2 diabetes.
Obstructive sleep apnea:
- This is when your breathing becomes irregular or stops during sleep. When it happens, it lowers oxygen levels in your blood and affects vital organs. While there’s no direct link between sleep apnea and MASLD, they share common risk factors such as obesity, insulin resistance, hypertension, type 2 diabetes, metabolic syndrome, and liver problems.
Impact on the Latino Community
Hispanic people in the U.S. are more prone to have complications related to MASLD. It affects almost half of Latino adults, compared to about 40% in other racial groups. In 2014, it affected only 29% of Hispanic people.
Also, 38% of Latino children and young adults between the ages of 12 and 29, particularly Mexican Americans, have been diagnosed with MASLD.
Blanca Lizaola-Mayo, MD, an associate professor of medicine in the Division of Gastroenterology and Hepatology at the Mayo Clinic College of Medicine, and medical director of the Liver Transplant Center at the Mayo Clinic in Arizona, explains that Hispanic people carry the PNPLA3 gene mutation, which increases the risk of fat buildup in the liver.
"As Hispanics, we have a gene or genetic predisposition to developing metabolic syndrome and fatty liver disease. This, in combination with the Western diet, which is high in chemicals, preservatives, fructose, and substances that lead to weight gain, results in liver disease," she states.
Other things that help to make MASLD so common in the Hispanic community are:
- Limited access to nutritious food
- Cultural barriers, such as lack of fluency in English
- Lack of adequate health insurance coverage
- Delayed or nonexistent diagnoses
- Misconceptions or stigma that link liver disease to alcohol consumption
- High rates of obesity and diabetes
"It is important to consider a patient’s culture and the types of food they consume. For example, if I have a Peruvian, Mexican, or any other Hispanic patient and I recommend foods they have never eaten before, we won’t get anywhere," Lizaola-Mayo explains.
"One of the most common questions I get is: 'What diet should I follow to improve my fatty liver disease?' My answer is: A diet that is healthy, that you enjoy, and that you can maintain," she adds.
The Importance of Early Diagnosis
People often link liver disease to alcohol consumption. But you can get these conditions even though you drink very little or not at all.
MASLD and MASH are challenging to diagnose, and many people are unaware they have them until the inflammation in their liver gets worse. Symptoms such as fatigue, belly discomfort, or pain in the upper right abdomen (belly area) may appear.
Detecting MASLD and MASH early is key to preventing severe complications. Your doctor may recommend several tests, including:
- Blood tests
- Ultrasound or sonogram
- Imaging tests to assess liver stiffness and fibrosis
Treatment for MASLD and MASH needs to address all the different things involved to prevent serious complications such as cirrhosis or liver cancer. Because of the link between these liver conditions and a higher rate of death from heart disease, it’s important to get early and regular medical screening.
Lifestyle Changes
Adjusting your lifestyle is the key to managing MASLD and keeping it from becoming MASH. Losing 7%-10% of your body weight can help reduce fat buildup and swelling in the liver.
Suggestions for lifestyle changes:
- Quit smoking.
- Avoid alcohol.
- Eat a balanced diet with plenty of fruits and vegetables.
- Eat lean protein.
- Limit your intake of red meat, refined flours, white sugars, and sugary drinks.
- Get regular exercise.
- Take steps to lower your cholesterol levels.
- Manage diabetes well.
- Review the medicines you take to be sure they don’t hurt your liver.
Healthy Alternatives
Lizaola-Mayo does not recommend natural, alternative, or holistic treatments for MASLD and MASH. She also doesn’t support extreme diets, as they are not sustainable long-term.
According to research, "the Mediterranean diet offers the greatest cardio-metabolic benefits" because it is "high in healthy fats, olive oil, avocado, nuts – all of which have anti-inflammatory properties." Black coffee is also included among beverages shown to help the liver, and she recommends consuming it without sugar or cream.
Medical Interventions
When lifestyle changes aren’t enough, your doctor may recommend prescription treatments. GLP-1 receptor agonists, such as semaglutide, liraglutide, and tirzepatide, can help you lose weight, and lower inflammation and fat buildup in the liver.
In 2024, the FDA approved resmetirom (Rezdiffra) for treating MASH with moderate to advanced liver fibrosis. This treatment may help reduce liver scarring. You use it along with a healthy diet and regular exercise.
Adopting these lifestyle changes can help you slow the progression of MASLD and reduce symptoms. In some cases, it can even reverse fatty liver disease.
Also, regular screening tests are key for assessing your liver health.
Your Outlook
Both MASLD and MASH are treatable diseases. As Lizaola-Mayo explains, "more medications are being approved by the FDA specifically for the treatment of fatty liver disease."
So it is crucial to "understand this highly prevalent disease in our population, have access to a healthy diet, good medical care, and effective treatments that help us make lifestyle changes. Ultimately, these changes will improve metabolic syndrome and help treat fatty liver disease."
Recap
- MASLD and MASH are liver diseases that can lead to severe complications, such as fibrosis, cirrhosis, or liver cancer.
- They affect Hispanic people at a higher rate than other groups for social, genetic, and health reasons that include a high rate of obesity and type 2 diabetes.
- These conditions are connected to illnesses such as hypertension, cardiovascular disease, and kidney damage.
- Early diagnosis and lifestyle changes can make a difference. Adopt healthy habits, stay informed, and talk to your doctor to prevent and manage these diseases.
Show Sources
Photo Credit: iStock/Getty Images
SOURCES:
Blanca Lizaola-Mayo, MD, associate professor of medicine, Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine; medical director, Liver Transplant Center, Mayo Clinic, Arizona.
Manual Merck: "Metabolic Dysfunction-Associated Liver Disease (MASLD)."
TuSaludmag.com: "Four in 10 U.S. Adults Affected by MASLD."
VCUHealth: "More than 40% of U.S. adults have liver disease, with higher risk among Hispanics, new study finds."
Cleveland Clinic: "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)."
Mayo Clinic: "Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD)," "The silent liver disease experts warn is on the rise among Hispanics and children."
BMJ Journals: "MASLD: a systemic metabolic disorder with cardiovascular and malignant complications."
National Lipid Association: "Practical Pearls: Dyslipidemia Management in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)."
ScienceDirect: "Current status and future trends of the global burden of MASLD."
Clinical and Experimental Hepatology: "Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor."
Tcoyd.org: "What to Know about MASLD and MASH: Two Liver Conditions that Can Affect People with Diabetes."
American College of Gastroenterology: "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)."
Mayo Clinic: "Sleep apnea."
American Liver Foundation: "NASH Causes & Risk Factors," "Cirrhosis of the Liver."